The group will not shy away from global buyout activity and will continue to make significant investments in both existing as well as new businesses, including in the digital space to meet its vision 2025 targets.
Posts tagged MC
Sensex falls over 100 pts, Nifty nears 7750; FMCG down 2% (07-12-2015)
ITC tanks 6 percent, while Coal India, ONGC, NTPC and Reliance are laggards. Sun Pharma, Tata Steel, Lupin and HDFC are top gainers in the Sensex. FMCG index is dow n over 2 percent while pharma index is up 0.8 percent.
Sensex, Nifty remain sluggish; Reliance slips, HDFC gains (07-12-2015)
Sun Pharma, Tata Steel, Lupin, HDFC and Vedanta are top gainers while ITC, Coal India, ONGC, NTPC and Reliance are among losers in the Sensex.
To maintain 10-12% $ revenue growth in FY16: Persistent Sys (07-12-2015)
Anand Deshpande, founder, MD CEO says that the company is on lookout for more acquisitions to expand its customer base.
‘Why mkt is consolidating; and why there’s good news ahead’ (07-12-2015)
The washout of successive Parliamentary sessions has cost the Indian market, which has entered into a consolidation phase right since the Budget session earlier this year, believes Manish Chokhani, Director with Enam Holdings.
Bharat Forge hits 52-week low on truck orders inflow fall (07-12-2015)
With reiterating underperform rating on the stock and keeping a target price of Rs 740 apiece, Bank of America Merrill Lynch says it sees increased downside risk for the company due to consistent fall in order inflow.
Sin tax on tobacco to hurt ITC, say analysts; stock dips 6% (07-12-2015)
IDFC believes it will be a huge negative for ITC as that will significantly increase its tax incidence and would require another steep price increase (of roughly 15-17 percent to pass on tax increase). The brokerage has an underperform rate on the stock with a target price of Rs 311 per share.
Sin tax on tobacco to hurt ITC, say analysts; stock dips 5% (07-12-2015)
IDFC believes it will be a huge negative for ITC as that will significantly increase its tax incidence and would require another steep price increase (of roughly 15-17 percent to pass on tax increase). The brokerage has an underperform rate on the stock with a target price of Rs 311 per share.
Sun Pharma up 3%, analysts bet on anti-cancer drug Gleevec (07-12-2015)
Nomura expects Sun Pharma to earn USD 370 million in revenue during 6-month exclusivity period for Gleevec. It feels earnings support from Gleevec and Ranbaxy synergy limited downside risk.
Sensex, Nifty continue to struggle; NTPC, Coal India drag (07-12-2015)
Sun Pharma continues to rally 3 percent while Tata Steel, Hindalco, HDFC Bank and Hero Motocorp are top gainers in the Sensex. Among the losers are ITC, NTPC, Coal India, ONGC and Dr Reddy’s Labs.